ZBH · 8-K · 20260805PR335108

Segment Revenue Recast

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 18 · Surprise 42 · In source text

In the quarter ended March 31, 2026, Zimmer Biomet changed the composition of its operating segments based on revised responsibilities reporting to the chief operating decision maker. Foot and Ankle results in EMEA and Asia Pacific were moved into the Americas operating segment. Centralized R&D and global marketing expenses were also assigned to Americas. The filing recasts selected 2025 Form 10-K MD&A and financial-statement disclosures without updating other subsequent events or information.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
operating_incomepositiverealizedIn the Americas, operating profit increased in 2025 primarily due to the acquisition of Paragon 28 and opportunistic end-of-year customer…
marginnegativerealizedIn the Americas, operating profit increased in 2025 primarily due to the acquisition of Paragon 28 and opportunistic end-of-year customer…